Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby et al., The Lancet Infectious Diseases, doi:10.1016/S1473-3099(25)00093-3 (preprint 5/24/2024)
https://c19early.org/horby.html